TrademarkOpen
Search / United States / 99764772

Heads up: we show every live trademark, plus inactive ones from the last 5 years, in the United States, Singapore, Canada, Australia and France. India is looked up live when you search, so it is not a saved copy of every mark, and it can be busy some days. Data is only as fresh as each country publishes it, and some countries aren’t included yet, so a brand can be registered even if it doesn’t show here. Always check the official record before you use a name. This is not legal advice.

🇺🇸 United States · Trademark

SOFRYLVI

Allowed — statement of use stage
Notice Of Allowance - Issued
Used for: Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alcohol use disorder, alopecia…
Show more

Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alcohol use disorder, alopecia, Alzheimer’s disease, asthma, atopic dermatitis, autoimmune diseases and disorders, blood diseases and disorders, cancer, cardiovascular disease, central nervous system diseases and disorders, Crohn’s disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, hearing loss, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, mental disorders, metabolic diseases and disorders, m…

Class 5 – Pharmaceuticals & supplements

Status timeline

  1. 15 Apr 2026
    Application filed
    New Application Entered
  2. 12 May 2026
    Assigned to an examining attorney
    Assigned To Examiner
  3. 14 May 2026
    Approved for publication
    Approved For Pub - Principal Register
  4. 9 Jun 2026
    Published for opposition
    Published For Opposition
  5. 4 Aug 2026
    Notice of allowance issued — statement of use required
    Noa Mailed - Sou Required From Applicant
All 9 events
2026-08-04Noa Mailed - Sou Required From Applicant
2026-06-09Published For Opposition
2026-06-09Official Gazette Publication Confirmation E-Mailed
2026-06-03Notification Of Notice Of Publication E-Mailed
2026-05-14Approved For Pub - Principal Register
2026-05-12Assigned To Examiner
2026-04-15New Application Entered
2026-04-15New Application Office Supplied Data Entered
2026-04-15Application Filing Receipt Mailed

Goods & services by class

Class 5 Pharmaceuticals & supplements

Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alcohol use disorder, alopecia, Alzheimer’s disease, asthma, atopic dermatitis, autoimmune diseases and disorders, blood diseases and disorders, cancer, cardiovascular disease, central nervous system diseases and disorders, Crohn’s disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, hearing loss, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, mental disorders, metabolic diseases and disorders, m…

Owner details

See the official record for contact details. View official record →

Source & freshness

Source: the official United States trademark register. This record was last updated on 4 Aug 2026; the index was built on 20 Nov 2026 and covers data through 31 Aug 2026. View official record → If the two differ, the official record is correct.